BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND FANCF, FAF, 2188, ENSG00000183161, Q9NPI8, MGC126856 AND Treatment
3 results:

  • 1. The risk of weekend biopsy: Impact of specimen source and fixation status on HER2 assessment in the treatment of advanced gastric cancer (The HER_WEEKEND study).
    Nakamura M; Watanabe A; Yoshizawa A; Iwasaki S; Nomura A; Matsumura M; Murai T; Itaya K; Koike Y; Izumi T; Endo A; Kato S; Ono Y; Ohshima T; Okazaki N; Nakagawa S; Ishii Y; Fukasawa Y; Yokota I; Tsuji T; Nishikawa S
    Pathol Int; 2023 Oct; 73(10):509-519. PubMed ID: 37589434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Insufficient lymph node assessment in gastric adenocarcinoma.
    Khanjani N; Mirzaei S; Nasrolahi H; Hamedi SH; Mosalaei A; Omidvari S; Ahmadloo N; Ansari M; Sobhani F; Mohammadianpanah M
    J Egypt Natl Canc Inst; 2019 Oct; 31(1):2. PubMed ID: 32372269
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
    Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
    Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.